Tgf beta. - OmicsDI

OmicsDI

Browse
Submit Data
Databases
API
Help

20063 Results

Show all Save search Copy query

Show results for

Unknown (12675)
Transcriptomics (4169)
Genomics (2674)
Proteomics (379)
Other (58)
Models (41)
Metabolomics (28)
Methylation profiling (21)
Multiomics (9)
Clinical (7)

Organisms

Homo sapiens (2800)
Mus musculus (1681)
Rattus norvegicus (134)
Drosophila melanogaster (50)
Bos taurus (48)
Gallus gallus (26)
Caenorhabditis elegans (24)
Danio rerio (24)
Saccharomyces cerevisiae (21)
Sus scrofa (19)
Xenopus laevis (14)
Macaca mulatta (14)
Canis lupus familiaris (12)
Oryctolagus cuniculus (9)
Arabidopsis thaliana (8)
cellular organisms (5)
Schistosoma mansoni (5)
Ovis aries (4)
Callithrix jacchus (3)
Anas platyrhynchos (3)
Papio anubis (3)
Vertebrata (2)
Rattus rattus (2)
Coturnix japonica (2)
Schizosaccharomyces pombe (2)
Helicobacter pylori (2)
Mus sp. (1)
Mammalia (1)
Panthera tigris altaica (1)
Saccharomyces cerevisiae W303 (1)

Organisms

Homo sapiens (964)
Mus musculus (710)
Rattus norvegicus (45)
Drosophila melanogaster (21)
Danio rerio (16)
Bos taurus (15)
Caenorhabditis elegans (14)
Gallus gallus (9)
Sus scrofa (9)
Macaca mulatta (8)
Oryctolagus cuniculus (7)
Canis lupus familiaris (5)
unidentified (4)
Leiocassis longirostris (3)
Ciona robusta (3)
Xenopus laevis (3)
Homo sapiens/Mus musculus xenograft (2)
Echinococcus granulosus (2)
Carassius gibelio (2)
Schistosoma mansoni (2)
Mammalia (2)
Capra hircus (2)
Ovis aries (2)
Acipenser sinensis (1)
Macaca nemestrina (1)
Tilapia (1)
Papio hamadryas (1)
Heterorhabditis indica (1)
Schmidtea mediterranea (1)
Euarchontoglires (1)

Repository

biostudies-arrayexpress (2913)
ENA (2142)
geo (1782)
pride (142)
EGA (93)
MassIVE (88)
jPOST (72)
iProX (56)
BioModels (26)
MetaboLights (26)
Cell Collective (14)
ExpressionAtlas (9)
LINCS (9)
GPMDB (6)
PanoramaPublic (5)
MetabolomicsWorkbench (2)
EVA (1)
FAIRDOMHub (1)
PAXDB (1)
PeptideAtlas (1)

Tissue

Cell culture (49)
Fibroblast (21)
Epithelial cell (12)
Liver (8)
Lung (6)
Blood (5)
Blood serum (4)
Heart (4)
Kidney (4)
Permanent cell line cell (4)
T cell (4)
Brain (3)
Keratinocyte (3)
Stem cell (3)
Blood cell (2)
Blood plasma (2)
Bone marrow (2)
Cerebral cortex (2)
Colon (2)
Hepatic stellate cell (2)
Macrophage (2)
Melanocyte (2)
Peritoneum (2)
Spleen (2)
Testis (2)
Lung (1)
Blood (1)
Others (1)
Aorta thoracica (1)
Bone (1)

Disease

Normal (15)
Breast cancer (10)
Glioblastoma multiforme (4)
Prostate cancer (4)
Adenocarcinoma (3)
Colon adenocarcinoma (2)
Glioblastoma (2)
Breast carcinoma (2)
Tuberculosis (1)
Multiple sclerosis (1)
Metastatic colorectal cancer (1)
Early onset preeclampsia (1)
Integrated HPV16 only (1)
Normotensive (1)
Idiopathic pulmonary fibrosis (1)
Embryonal Carcinoma (1)
Intestinal type gastric cancer (1)
Hepatocellular carcinoma-non tumorous region (1)
Tumor (1)
Aorta aneurysm (1)
Pre-tumoral lesion in a mouse model of human adamantinomatous craniopharyngioma (ACP) (1)
Follicular thyroid carcinoma (1)
Basal cell carcinoma, Gorlin-Goltz syndrome (1)
Crohn's disease (1)
Rheumatoid arthritis (1)
Colorectal cancer (1)
Invasive lobular carcinoma (1)
Leukemia (1)
Melanoma (1)
Cervical carcinoma (1)

Technology Type

Mass Spectrometry (144)
Shotgun proteomics (67)
Bottom-up proteomics (32)
Mass spectrometry (21)
Data-dependent acquisition (18)
Affinity purification coupled with mass spectrometry proteomics (13)
Data-independent acquisition (13)
Gel-based experiment (10)
Fluorescence intensity (6)
Fluorescence imaging (5)
Top-down proteomics (5)
Illumina HiSeq 2000 (4)
Mass spectrometry assay (4)
HDMSE (4)
All-ion fragmentation (3)
SWATH MS (3)
ILLUMINA, Illumina HiSeq 2500 (2)
ILLUMINA, Illumina HiSeq 2000 (2)
SRM/MRM (2)
Codelink Human Whole Genome Bioarray (1)
Illumina HiSeq 2500, ILLUMINA (1)
Illumina HiSeq 4000, Illumina HiSeq 2500, ILLUMINA (1)
Illumina ChIP-Sequencing, Illumina MBD-Sequencing, Illumina beadarray, Illumina HiSeq 2500, Illumina MiSeq, Illumina Bisulfite-Sequencing (1)
Affymetrix SNP 6.0, Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000, ILLUMINA (1)
Microwestern (1)
NMR spectroscopy (1)
Other (1)
ESI (1)

Instrument Platform

Illumina NovaSeq 6000 (83)
Illumina HiSeq 2500 (45)
Illumina HiSeq 4000 (45)
NextSeq 500 (43)
Illumina HiSeq 2000 (29)
NextSeq 550 (7)
Illumina Genome Analyzer IIx (6)
NextSeq 2000 (6)
Illumina HiSeq 3000 (6)
Illumina NovaSeq X (5)
Illumina MiSeq (5)
Scanning hardware (4)
Axon GenePix 4000B scanning hardware (4)
Illumina Genome Analyzer II (3)
Computer (2)
Microcentrifuge (2)
Axon Instruments GenePix 4000B scanner (2)
Qiagen (2)
AB 5500 Genetic Analyzer (2)
G2500A Hewlett Packard (2)
AB SOLiD System 3.0 (2)
BAS-5000 [FUJIFILM] (2)
418 [Affymetrix] (2)
ScanArray Express HT [PerkinElmer] (2)
ScanArray 4000XL [PerkinElmer] (2)
Standard laboratory equipment for RNA library construction (1)
Agilent Bioanalyser for RNA quality control (1)
Laboratory greezer (-80C storage) and dry ice for snap-freezing (1)
BD FACS Aria II (1)
BD FACS ARIA III analyser (1)

Publication Date

2015 (408)
2014 (403)
2013 (402)
2012 (365)
2025 (335)
2011 (305)
2010 (302)
2024 (292)
2026 (276)
2016 (261)
2021 (233)
2022 (229)
2023 (212)
2008 (202)
2020 (174)
2009 (140)
2018 (139)
2019 (135)
2017 (116)
2007 (110)
2006 (33)
2005 (30)
2004 (16)
2003 (5)

UNIPROT ID/AC

P01137 (9)
Q13485 (5)
P36897 (5)
Q15796 (4)
P37173 (4)
Q8NER5 (2)
P04202 (2)
Q14609 (1)
P06238 (1)
P20961 (1)
Q71SA3 (1)
P17246 (1)
P29598 (1)
Q01177 (1)
Q15116 (1)
P16410 (1)
P49767 (1)
O75636 (1)
O00602 (1)
Q96A83 (1)
Q96CG8 (1)
Q2UY09 (1)
Q8IZC6 (1)
Q9BXS0 (1)
Q17RW2 (1)
Q86Y22 (1)
Q8NFW1 (1)
Q9Y215 (1)
Q96P44 (1)
Q9P218 (1)

ENSEMBL ID

ENSMUSG00000031170 (1)
ENSMUSG00000010064 (1)
ENSMUSG00000024036 (1)
ENSMUSG00000020261 (1)
ENSMUSG00000031156 (1)
ENSMUSG00000037434 (1)
ENSMUSG00000025082 (1)
ENSMUSG00000070436 (1)
ENSMUSG00000037936 (1)
ENSMUSG00000015533 (1)
ENSMUSG00000042284 (1)
ENSMUSG00000041559 (1)
ENSMUSG00000026938 (1)
ENSMUSG00000021553 (1)
ENSMUSG00000004415 (1)
ENSMUSG00000054196 (1)
ENSMUSG00000068794 (1)
ENSMUSG00000045672 (1)
ENSMUSG00000058897 (1)
ENSMUSG00000028197 (1)
ENSMUSG00000063564 (1)
ENSMUSG00000079022 (1)
ENSMUSG00000057606 (1)
ENSMUSG00000016356 (1)
ENSMUSG00000046959 (1)
ENSMUSG00000024354 (1)
ENSMUSG00000026141 (1)
ENSMUSG00000001435 (1)
ENSMUSG00000025064 (1)
ENSMUSG00000040690 (1)

CHEBI ID

CHEBI:28728 (4)
CHEBI:36575 (3)
CHEBI:15493 (1)
CHEBI:35222 (1)
CHEBI:28092 (1)
CHEBI:2070 (1)
CHEBI:21285 (1)
CHEBI:18402 (1)
CHEBI:16466 (1)
CHEBI:28508 (1)
CHEBI:28095 (1)
CHEBI:15494 (1)
CHEBI:16577 (1)
CHEBI:57495 (1)
CHEBI:16934 (1)
CHEBI:28189 (1)
CHEBI:1949 (1)
CHEBI:58321 (1)
CHEBI:9907 (1)
CHEBI:28922 (1)
CHEBI:28852 (1)
CHEBI:34939 (1)
CHEBI:27696 (1)
CHEBI:27555 (1)
CHEBI:15546 (1)
CHEBI:28099 (1)
CHEBI:27624 (1)
CHEBI:16325 (1)
CHEBI:17617 (1)
CHEBI:27453 (1)

Metabolite Name

L-Lysine (8)
Thymine (7)
Choline (7)
Creatinine (7)
Creatine (7)
Uracil (6)
L-Aspartic acid (6)
L-Histidine (6)
Indole (6)
L-Proline (6)
L-Tryptophan (6)
L-Valine (6)
L-Methionine (6)
L-Tyrosine (6)
L-Phenylalanine (6)
Thiamine (5)
Kynurenic acid (5)
Taurine (5)
Ectoine (5)
Adenosine (5)
Guanine (5)
Sarcosine (5)
N-Acetyl-L-alanine (5)
Adenine (5)
Guanosine (5)
Uridine (5)
Inosine (5)
Hypoxanthine (5)
2'-Deoxyadenosine (4)
Isonicotinic acid (4)

First Public Date

2025 (306)
2026 (284)
2014 (280)
2024 (245)
2022 (171)
2023 (169)
2021 (149)
2020 (130)
2019 (123)
2017 (82)
2018 (77)
2015 (65)
2016 (42)
2013 (19)

Modelling Approach

Ordinary differential equation model (18)
Logical model (3)
Fuzzy logic model (1)
Boolean model (1)
Differential equation model (1)

Study status

Completed (5)
Withdrawn (1)
Not provided (1)

Lab affiliation

National Health Research Institutes, Taiwan (3)
University of Vigo (3)
Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (2)
Guangdong Pharmaceutical University (2)
Head Proteomics Group, Leiden University Medical Center, Center for Proteomics and Metabolomics, PO Box 9600, Postal zone P1-Q, 2300 RC Leiden, The Netherlands (2)
SIMM (2)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (2)
1 IBMC-Institute for Molecular and Cell Biology, i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal 2 ICBAS-School of Medicine and Biomedical Sciences, Universidade do Porto, Porto, Portugal (1)
2Division of Pharmaceutical Sciences, School of Pharmacy, University of Wisconsin-Madison, Madison, Madison, WI 53705, USA (1)
Advanced Mass Spectrometry Center, Research Core Facility, Frontiers Scienc Center for Disease-Related Molecular Network, West China Hospital (1)
Alfred E. Mann Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, 90089, USA Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine of USC, Los Angeles, CA, 90033, USA (1)
Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER) - University of Seville (1)
Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA (1)
Augusta University (1)
BK21 Plus KNU Multi-Omics-based Creative Drug Research Team, College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Republic of Korea (1)
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) School of Life Sciences Technical University Munich (TUM) Gregor-Mendel-Straße 4 85354 Freising GERMANY Bavarian Center for Biomolecular Mass Spectrometry Technische Universität München Gregor-Mendel-Straße 4 85354 Freising DEUTSCHLAND / GERMANY (1)
Bertis R&D Division, Bertis Inc., Republic of Korea (1)
Biochemistry, University of Turku, Turku, Finland (1)
Biozentrum, University of Basel, Klinglebergstrasse 50/70, CH-4056 Basel (1)
Bone and Cartilage Research Unit, Arthropôle Liège, University of Liège, Liège, Belgium (1)
Bram Snijders Head of Mass Spectrometry Proteomics Platform The Francis Crick Institute 1 Midland Road London NW1 1AT T: +442037962038 E: bram.snijders@crick.ac.uk W: https://crims.crick.ac.uk/ (1)
COld Spring Harbor Laboratory (1)
CRCM (Marseille Protéomique), Inserm U1068, Institut Paoli-Calmettes, Aix-Marseille Université, UM105, CNRS UMR7258, Marseille (1)
CRUK - Scotland Institute - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)
Cellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Science, Naresuan University, Phitsanulok, 65000, Thailand (1)
Cellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, 65000, Thailand (1)
Cellular and Molecular Immunology Research Unit (CMIRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand (1)
Center for Kidney Disease, 2nd Affiliated Hospital, Nanjing Medical University, Nanjing, Jiangsu 210003, China (1)
Center for Translational Medicine, The Affiliated Zhangjiagang Hospital of Soochow University, Suzhou Medical College of Soochow University (1)
Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, Gliwice, Poland (1)

Keyword

Capecitabine (2)
TGF- beta activated (1)
Trabedersen (1)
Advanced tumor (1)
Antisense (1)
Transforming Growth Factor beta 2 (1)
Stage I salivary gland cancer (1)
Stage II salivary gland cancer (1)
Metastatic squamous neck cancer with occult primary squamous cell carcinoma (1)
High-grade salivary gland mucoepidermoid carcinoma (1)
Salivary gland adenocarcinoma (1)
Salivary gland adenoid cystic carcinoma (1)
Salivary gland anaplastic carcinoma (1)
Salivary gland malignant mixed cell type tumor (1)
Salivary gland poorly differentiated carcinoma (1)
Salivary gland squamous cell carcinoma (1)
Low-grade salivary gland mucoepidermoid carcinoma (1)
Salivary gland acinic cell tumor (1)
Stage III salivary gland cancer (1)
Stage IV salivary gland cancer (1)
Recurrent salivary gland cancer (1)
Male breast cancer (1)
Stage III squamous cell carcinoma of the hypopharynx (1)
Stage IV squamous cell carcinoma of the hypopharynx (1)
Recurrent squamous cell carcinoma of the hypopharynx (1)
Stage III squamous cell carcinoma of the larynx (1)
Stage III verrucous carcinoma of the larynx (1)
Stage IV squamous cell carcinoma of the larynx (1)
Stage IV verrucous carcinoma of the larynx (1)
Recurrent squamous cell carcinoma of the larynx (1)

IsPrivate

False (26)

Model Flag

Non Kinetic (1)

Submitter Keywords

Immuno-oncology (5)
Oncology (1)
Not Peer Reviewed (1)

Classification

helminths (4)

Modification

-17.026549 (1)
15.994915 (1)
42.010565 (1)
6.020129 (1)

Study type

Transcription profiling by array (1904)
RNA-seq of coding RNA (358)
ChIP-seq (171)
Methylation profiling by array (55)
RNA-seq of coding RNA from single cells (53)
Unknown experiment type (52)
Comparative genomic hybridization by array (52)
RNA-seq of non coding RNA (34)
Other (31)
Cell line - High-throughput sequencing (20)
ChIP-chip by tiling array (19)
Transcription profiling by RT-PCR (18)
MicroRNA profiling by array (15)
Genotyping by array (13)
ChIP-chip by array (11)
Human - High-throughput sequencing (10)
DNA-seq (10)
Methylation profiling by high throughput sequencing (9)
RNA-seq of total RNA (8)
Transcription profiling by SAGE (7)
Proteomic profiling by array (7)
Cell line - One-color microarray (6)
Cell line - Single-cell sequencing (3)
Human - One-color microarray (3)
Animal - High-throughput sequencing (3)
Single nucleus RNA sequencing (3)
Baseline (2)
MNase-seq (2)
Differential (2)
Animal - One-color microarray (2)

Release Date

2022 (1453)
2021 (1316)
2025 (1223)
2023 (1209)
2020 (1098)
2024 (1014)
2019 (875)
2015 (854)
2014 (800)
2016 (768)
2017 (740)
2018 (715)
2013 (664)
2012 (638)
2011 (523)
2010 (476)
2008 (297)
2009 (292)
2026 (191)
2007 (176)
2006 (81)
2005 (66)
2004 (40)
2003 (16)
2002 (15)
2000 (15)
2001 (10)
1999 (6)
1997 (5)
1998 (3)

Location

Spain (2)
Australia (1)
Japan (1)
Italy (1)
Belgium (1)
Germany (1)
Netherlands (1)
United States (1)

Previous page
1 / 2007
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 2007
Next page

Sort by:

Relevance

Page size

TGF-β uncouples glycolysis and inflammation in macrophages and controls the survival during sepsis

The mechanisms by which macrophage metabolism is regulated and the effects of metabolism on diseases remain largely unknown. We show here that TGF-β regulates the glycolysis of macrophages independently of inflammatory cytokine production, and thus affects the survival in experimental sepsis. Spe...

2023-02-17 | MTBLS6886 | MetaboLights

HNF4A-binding sites in HepG2 hepatoblastoma cells treated with TGF-beta

Specific regulation of target genes by transforming growth factor-β (TGF-β) in a given cellular context is determined in part by transcription factors and cofactors that interact with the Smad complex. In the present study, we determined Smad2 and Smad3 (Smad2/3) binding regions in the promoters of ...

ORGANISM(S): Homo sapiens

2011-06-08 | E-GEOD-28845 | biostudies-arrayexpress

Expression data from TGF-beta-treated human ovarian fibroblasts

Advanced ovarian cancer is the most lethal gynecologic malignancy in the United States. Ovarian cancer cells are known to have diminished response to TGF-beta, but it remains unclear whether TGF-beta can modulate ovarian cancer cell growth in an indirect manner through cancer-associated fibroblasts ...

ORGANISM(S): Homo sapiens

2013-12-31 | E-GEOD-40266 | biostudies-arrayexpress

Human osteoblast treated with recombinant TGF-beta

Global expression profile of human osteoblast treated with recombinant TGF-beta compared to human osteoblast treated with growth media alone Dye-swap design with 6 biological replicates. Three arrays performed with TGF-beta treated samples on channel 1 and media-alone treated on channel 2; three arr...

ORGANISM(S): Homo sapiens

2010-09-29 | E-GEOD-17843 | biostudies-arrayexpress

Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling

Imbalances in glucose and energy homeostasis are at the core of the worldwide epidemic of obesity and diabetes. Here, we illustrate an important role of the TGF-beta/Smad3 signaling pathway in regulating glucose and energy homeostasis. Smad3 deficient mice are protected from diet-induced obesity and...

ORGANISM(S): Mus musculus

2011-07-12 | E-GEOD-28598 | biostudies-arrayexpress

Transcription profiling of primary human macrophages treated with TGF-beta

The goal of the study was to identify the effects of TGF-beta on primary human macrophages maturated under different conditions. Experiment Overall Design: For the analysis of TGF-beta effects macrophages were differentiated in the presence of IL-4 or IL-4 in combination with dexamethasone. After 5 ...

ORGANISM(S): Homo sapiens

2008-06-20 | E-GEOD-7568 | biostudies-arrayexpress

TGF-beta specific gene expression signatures in breast cancer stem cells

Analyze TGF-beta pathway transcriptional regulation in breast cancer stem cells with different responses upon TGF-beta pathway activation. Total RNA from four breast cell lines grown as mammospheres treated with recombinant TGF-beta or a TGF-beta receptor I inhibitor was used in the analysis.

ORGANISM(S): Homo sapiens

2012-02-09 | E-MTAB-516 | biostudies-arrayexpress

Expression data from normal murine mammary epithelial cell line NMuMG stimulated with TGF-beta

TGF-beta is one of the most important cytokines that induce epithelial to mesenchymal transition (EMT). In this dataset, we examined TGF-beta induced changes in gene and exon level expression. Core probesets of two samples were analyzed. NMuMG cells were stimulated with TGF-beta for 24 h or left unt...

ORGANISM(S): Mus musculus

2011-11-01 | E-GEOD-28184 | biostudies-arrayexpress

Transcription profiling of human glioma cells treated with TGF-beta or an inhibitor of the TGF-beta Receptor I LY2109761

In order to identify the genes that are regulated by TGF-beta in glioma, we serum starved two glioma cell lines, U373MG and U87MG, for 16h and we treated them with vehicle,100pM TGF-beta, 2uM inhibitor of the TGF-beta Receptor I(TbRI)(LY2109761), or both 100pM TGF-beta plus 2uM TbRI for 3h. Then, ce...

ORGANISM(S): Homo sapiens

2007-05-16 | E-MEXP-903 | biostudies-arrayexpress

TGF-beta-mediated microRNA expression in breast cancer cells

We utilized 3D-organotypic cultures whose physical properties were altered by inclusiong of type I collagen to create biomechanically rigid microenvironments that approximated those typically observed in primary mammary tumors. Compliant 3D-organotypic cultures were also generated to recapitulate t...

ORGANISM(S): Mus musculus

2012-10-31 | E-GEOD-41274 | biostudies-arrayexpress